Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with β-lactam antibiotics
- 1 May 2006
- journal article
- Published by Elsevier in Toxicology
- Vol. 222 (1-2) , 114-124
- https://doi.org/10.1016/j.tox.2006.02.004
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Comparative Cerebrospinal Fluid Diffusion of Imipenem and Meropenem in RatsJournal of Pharmacy and Pharmacology, 2000
- Imipenem but not meropenem induces convulsions in DBA/2 mice, unrelated to cerebrospinal fluid concentrationsFundamental & Clinical Pharmacology, 2000
- Low convulsive activity of a new carbapenem antibiotic, DK-35C, as compared with existing congenersToxicology, 1999
- Correlation between in vitro and in vivo models of proconvulsive activity with the carbapenem antibiotics, biapenem, imipenem/cilastatin and meropenemToxicology Letters, 1995
- The effect of cyclopyrrolones on GABAA receptor function is different from that of benzodiazepinesNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1994
- Low neurotoxicity of LJC 10,627, a novel 1 beta-methyl carbapenem antibiotic: inhibition of gamma-aminobutyric acidA, benzodiazepine, and glycine receptor binding in relation to lack of central nervous system toxicity in ratsAntimicrobial Agents and Chemotherapy, 1993
- Populations at Risk for Penicillin-Induced SeizuresAnnals of Pharmacotherapy, 1992
- Epileptogenic activity of some β-lactam derivatives: Structure-activity relationshipNeuropharmacology, 1989
- Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatinThe American Journal of Medicine, 1985
- Primaxin in the treatment of acute bacterial pneumonia in adultsJournal of Antimicrobial Chemotherapy, 1985